J CLIN MED 润色咨询

Journal of Clinical Medicine

出版年份：暂无数据 年文章数：15265 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：0.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2024-10-10 ms1000000387734113 来自上海

    中国医院的还有希望吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2023-07-11 qxlian1987 来自北京

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享：被主编秒拒

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2024-02-19 yh2

    2024年预警期刊！

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2024-06-04 塘朗村村民 来自美国

    已被医院预警，慎重选择

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2024-01-12 mastermaus 来自湖北省

    投稿命中率:5.0
    偏重的研究方向：医学;内科;分子标记
    经验分享：24-01-09投稿，24-01-12被拒，预测模型

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2023-12-13 1488cf0fm85暂无昵称 来自北京

    投稿2天，还是Pending review

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2023-02-09 哈哈大笑VVV 来自四川省

    偏重的研究方向：临床医学
    经验分享：已经七天了，还是pending review。。。

    8

    展开8条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2023-04-18 145ea306m02暂无昵称 来自辽宁省

    小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2023-01-31 ms4000000565826013 来自江苏省

    这个是预警期刊吗现在？

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2230153, encodeId=20de2230153b7, content=中国医院的还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d999111292, createdName=ms1000000387734113, createdTime=Thu Oct 10 13:01:25 CST 2024, time=2024-10-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147536, encodeId=f3e7214e5364e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：被主编秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b6689209, createdName=qxlian1987, createdTime=Tue Jul 11 21:31:29 CST 2023, time=2023-07-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188141, encodeId=a55e2188141b1, content=2024年预警期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Mon Feb 19 13:19:26 CST 2024, time=2024-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208299, encodeId=f98f220829927, content=已被医院预警，慎重选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ba75479400, createdName=塘朗村村民, createdTime=Tue Jun 04 18:41:52 CST 2024, time=2024-06-04, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向：医学;内科;分子标记<br>经验分享：24-01-09投稿，24-01-12被拒，预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2174660, encodeId=99ec21e4660fc, content=投稿2天，还是Pending review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7e75312121, createdName=1488cf0fm85暂无昵称, createdTime=Wed Dec 13 10:09:05 CST 2023, time=2023-12-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向：临床医学<br>经验分享：已经七天了，还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信，真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1071490, encodeId=5f8610e1490b0, content=审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0<br>偏重的研究方向：肿瘤学;影像识别;分子标记<br>经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6071712249, createdName=张太公钓虾米, createdTime=Thu Nov 18 18:43:07 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-18 张太公钓虾米

    审稿速度:2.0 | 投稿命中率:95.0 | 审稿费用:2200.0
    偏重的研究方向：肿瘤学;影像识别;分子标记
    经验分享：10月8日投稿，10月22日收到大修通知（3份审稿报告，2个建议很详细，1个一般），改了差不多10天吧，11月11日接收，速度很快。没发生秒拒的情况啊，还是看稿件质量吧。。。

    3

    展开3条回复
共166条页码: 1/17页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分